{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:01:44Z","timestamp":1772820104810,"version":"3.50.1"},"reference-count":0,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2003,10,29]],"date-time":"2003-10-29T00:00:00Z","timestamp":1067385600000},"content-version":"vor","delay-in-days":2280,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[1997,8]]},"abstract":"<jats:p>It has been shown that normal early progenitor or stem cells persist in the blood and bone marrow of patients with Philadelphia chromosome (Ph)\u2010positive chronic myeloid leukaemia (CML); it is also known that normal haemopoietic progenitors can be expanded <jats:italic>ex vivo<\/jats:italic> in the presence of various cytokine combinations. The selection of normal (Ph\u2010negative) progenitor cells from CML patients would potentially be of considerable clinical value for <jats:italic>ex vivo<\/jats:italic> purging and autologous transplantation. To obtain these cells, CD34\u2010positive (progenitor) cells from the peripheral blood (PB) of CML patients were pretreated with 5\u2010fluorouracil (5FU) (5\u2003\u03bcg\/ml) to suppress Ph\u2010positive cells and then grown in suspension culture for 7\u2003d with a combination of cytokines. We compared two combinations of cytokines: interleukin\u20101\u03b1 (IL1\u03b1) and interleukin\u20103 (IL3) with either Flt3\u2010ligand (FLT3L) or stem cell factor (SCF). Using these two combinations, we obtained the same degree of day 14 CFU\u2010GM expansion (3.1\u2003\u00b1\u20030.5 and 3.4\u2003\u00b1\u20030.7 fold expansion). FISH analysis showed that 5FU pretreatment significantly favoured a higher frequency of Ph\u2010negative cells after expansion in liquid culture. Moreover, after 5FU pretreatment, the mean (\u00b1SEM) percentage of Ph negativity was significantly greater for IL1\u03b1\u2010IL3\u2010FLT3L compared to IL1\u03b1\u2010IL3\u2010SCF (19.1\u2003\u00b1\u20032.5% <jats:italic>v<\/jats:italic> 14.8\u2003\u00b1\u20032.3%, <jats:italic>P<\/jats:italic>\u2003=\u20030.009, <jats:italic>n\u2003=\u2003<\/jats:italic>7). The output long\u2010term culture initiating cells (LTC\u2010IC) which could only be detected after 5FU pretreatment and the combination, IL1\u03b1\u2010IL3\u2010FLT3L were all Ph negative by FISH analysis. Thus, a subset of Ph\u2010negative cells was selected from CML PB by 5FU and expanded using the combination of cytokines IL1\u03b1\u2010IL3\u2010FLT3L and IL1\u03b1\u2010IL3\u2010SCF. <jats:italic>Ex vivo<\/jats:italic> expansion of putatively normal haemopoietic progenitor cells is feasible in CML.<\/jats:p>","DOI":"10.1046\/j.1365-2141.1997.2003017.x","type":"journal-article","created":{"date-parts":[[2003,11,6]],"date-time":"2003-11-06T15:24:19Z","timestamp":1068132259000},"page":"467-473","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Ex vivo cytokine expansion of peripheral blood 5\u2010fluorouracil\u2010treated CD34\u2010positive chronic myeloid leukaemia cells increases the selection of Ph\u2010negative cells"],"prefix":"10.1111","volume":"98","author":[{"given":"Fran\u00c7ois\u2010Xavier","family":"Mahon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Pigeonnier\u2010Lagarde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikmat","family":"Chahine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Barbot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bozena","family":"Jazwiec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Ripoche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josy","family":"Reiffers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,10,29]]},"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.1997.2003017.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.1997.2003017.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.1997.2003017.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T12:13:03Z","timestamp":1694434383000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.1997.2003017.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,8]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1997,8]]}},"alternative-id":["10.1046\/j.1365-2141.1997.2003017.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.1997.2003017.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,8]]},"assertion":[{"value":"2003-10-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}